News & Updates

Show Multimedia Only

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

26 Sep 2025 by

Broad-class psychotropic exposure during pregnancy is not associated with an increased risk of obstetric or neonatal complications, although certain subclasses may carry higher risks, according to a 19-year population-based study in Hong Kong.

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

26 Sep 2025

Menopausal hormone therapy poses cardiac risk for older women

24 Sep 2025 by

Hormone therapy for vasomotor symptoms (VMS) appears to raise the risk of atherosclerotic cardiovascular disease (ASCVD) for women exposed to the treatment later in life, according to a secondary analysis of two Women’s Health Initiative (WHI) trials.

Menopausal hormone therapy poses cardiac risk for older women

24 Sep 2025

Exposure to CT scan may raise risks for pregnancy loss, congenital anomalies

23 Sep 2025

Exposure to computed tomography (CT) imaging prior to pregnancy appears to increase the risks for spontaneous pregnancy loss and congenital anomalies, suggests a study. However, the mechanism driving this association remains unclear.

Exposure to CT scan may raise risks for pregnancy loss, congenital anomalies

23 Sep 2025

Hypertensive disorders of pregnancy may impair childhood neurodevelopment

22 Sep 2025 by

Hypertensive disorders of pregnancy (HDPs) appear to increase the odds of adverse neurodevelopmental and cognitive outcomes, such as autism and attention-deficit/hyperactivity disorder (ADHD), in the offspring, suggest the results of a meta-analysis.

Hypertensive disorders of pregnancy may impair childhood neurodevelopment

22 Sep 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-August-2025

22 Sep 2025

New drug applications approved by US FDA as of 1-15 August 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-August-2025

22 Sep 2025

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

18 Sep 2025 by

Among women who have previously had an ischaemic stroke, the use of vaginal estradiol tablets does not raise the risk of having another stroke, according to new research.

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

18 Sep 2025

Myo-inositol supplementation of no help in pregnant women with PCOS

16 Sep 2025

Daily myo-inositol supplementation does not appear to reduce the risk of pregnancy complications such as gestational diabetes, preterm birth, and pre-eclampsia in women with polycystic ovary syndrome (PCOS), according to a study.

Myo-inositol supplementation of no help in pregnant women with PCOS

16 Sep 2025

RSV, COVID-19, and pneumococcal disease vaccination updates in Singapore

16 Sep 2025

At the Singapore Thoracic Society (STS) Annual Scientific Meeting 2025, Dr Ian Wee Liang En from the Department of Infectious Diseases/Infection Prevention and Epidemiology, Singapore General Hospital, provided an update on respiratory viral infections and the evolving role of vaccination in reducing disease burden. Dr Wee, who has recently authored several publications on respiratory syncytial virus (RSV), SARS-CoV-2 Omicron, and influenza infections in Singapore, focused his presentation on RSV, with additional updates on COVID-19 and pneumococcal disease.